The University of Oklahoma College of Medicine has been facing an increase in complex infections over the past decade. This rise can be attributed to several factors, including the overall declining health of the population in the Sooner State, an increase in complex surgeries performed by the medical school’s surgeons, and a significant rise in the use of immunosuppressive therapeutics for various conditions.
One of the key challenges faced by the health system is the growing incidence of antimicrobial resistance, which limits treatment options to intravenous antibiotics. To address this issue and reduce the burden of prolonged hospital stays on patients, the outpatient parenteral antimicrobial therapy (OPAT) program was established. This program allows patients to receive intravenous antibiotics at home, often for extended periods, with the support of infusion companies and home health nurses.
However, a major concern with OPAT is ensuring patient adherence to antibiotic therapy, as lack of adherence can lead to treatment failure and hospital readmissions. To tackle this issue, the University of Oklahoma initiated a clinical trial to study the impact of remote therapeutic monitoring (RTM) technology on patients on OPAT. RTM enables healthcare staff to monitor patients’ infusion of antibiotics remotely, ensuring adherence to the prescribed treatment plan.
Preliminary results from the trial showed a significant reduction in infection-related readmissions among patients using RTM compared to those in the control group. The RTM technology provided real-time data on patient adherence, allowing for timely interventions and support for patients struggling with their home infusions. This proactive approach led to improved patient outcomes and a decrease in hospital readmissions.
The success of RTM in enhancing patient adherence and reducing readmissions underscores its potential as a valuable tool in healthcare delivery. The data generated by RTM not only improved clinical outcomes but also helped streamline antibiotic regimens and increase patient adherence. Patients enrolled in the trial reported feeling supported during their transition of care, emphasizing the importance of personalized support in achieving successful treatment outcomes.
In conclusion, the integration of RTM technology into clinical practice has the potential to revolutionize patient care, not only in OPAT settings but also in other home infusion models and pharmaceutical research. The University of Oklahoma’s experience with RTM highlights the transformative impact of remote monitoring on patient outcomes and underscores the importance of leveraging technology to enhance healthcare delivery.
